Text Size

Dose-Response of Exercise on Long-Term Weight Loss

This study has been completed.
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by:
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00177762
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted

September 13, 2005
September 13, 2005
September 1999
Not Provided
weight loss
Same as current
No Changes Posted
  • fitness
  • dietary intake
  • physical activity
  • mediators
  • body composition
Same as current
Not Provided
Not Provided
 
Dose-Response of Exercise on Long-Term Weight Loss
Dose-Response of Exercise on Long-Term Weight Loss

The purpose is to examine varying durations and intensities of exercise on long-term weight loss.
Not Provided
Interventional
Phase 1
Phase 2
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Obesity
  • Weight Loss
Behavioral: behavior weight loss
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
200
December 2002
Not Provided

Inclusion Criteria:

  1. Female
  2. 21-45 years of age
  3. BMI = 27-40 kg/m2
  4. Ability to provide informed consent.
  5. Ability to provide consent from their personal physician to participate in this study.

Exclusion Criteria:

  1. Reporting regular exercise participation of at least 20 minutes per day on at least 3 days per week during the previous six months. (This study is designed to recruit relatively sedentary adults.)
  2. Diabetes, hypothyroidism, or other medical conditions which would affect energy metabolism.
  3. Currently pregnant, pregnant within the previous six months, or planning on becoming pregnant within the next 24 months. (Pregnancy will be based on self-report and will be included on the detailed medical history that is completed by subjects.)
  4. Non-medicated resting systolic blood pressure >160 mmHg or non-medicated resting diastolic blood pressure >100 mmHg, or taking medication that would affect blood pressure.
  5. Taking medication that would affect resting heart rate or the heart rate response during exercise (e.g., beta blockade).
  6. Arrhythmia on resting or exercise electrocardiogram that would indicate that vigorous exercise was contraindicated.
  7. History of myocardial infarction or valvular disease.
  8. History of orthopedic complications that would prevent optimal participation in the exercise component (e.g., heel spurs, severe arthritis).
Female
21 Years to 45 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00177762
R01 HL64991
Not Provided
Not Provided
University of Pittsburgh
National Institutes of Health (NIH)
Principal Investigator: John M Jakicic, Ph.D. University of Pittsbugh
University of Pittsburgh
September 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP